Amplifying Scientific Innovation: Key Highlights

Special panel edition of the Amplifying Scientific Innovation Video Podcast that will focus on innovative approaches for optimizing clinical trial diversity during the JP Morgan Healthcare Conference, which is the largest and most informative healthcare investment symposium in the industry. Moderated by Dr. Sophia Ononye-Onyia, Founder and CEO, The Sophia Consulting Firm. Panel lineup:   

• Mr. Bert Bruce is the Regional President, North America, Rare Disease at Pfizer, one of the world's premier biopharmaceutical companies.
• Dr. Gary A. Puckrein is President and Chief Executive Officer of the National Minority Quality Forum (formerly the National Minority Health Month Foundation), a not-for-profit organization that he founded in 1998 with the goal of  strengthening the capacity of local communities to eliminate the disproportionate burden of premature death and preventable illness in minority populations. 
• Mr. Craig Lipset is an Advisor and Founder of Clinical Innovation Partners and former Head of Clinical Innovation at Pfizer. 
• Ms. Janet Lynch Lambert is the CEO of the Alliance for Regenerative Medicine, the leading international advocacy organization dedicated to regenerative medicines and advanced therapies. 
• Dr. Mimi Huizinga is the VP and Head, US Oncology Medical at Novartis Oncology, a leading global medicines company that is reimagining medicine to improve and extend people’s lives. 

For full transcript, please visit: https://sophiaconsultingfirm.com/blogs-and-articles/f/amplifying-scientific-innovationclinical-trial-diversity-jpm-pt2

Special panel edition of the Amplifying Scientific Innovation Video Podcast that will focus on innovative approaches for optimizing clinical trial diversity during the JP Morgan Healthcare Conference, which is the largest and most informative healthcare investment symposium in the industry. Moderated by Dr. Sophia Ononye-Onyia, Founder and CEO, The Sophia Consulting Firm. 

Panel lineup: 

• Dr. Craig Tendler, VP of Clinical Development and Global Medical Affairs, Oncology at Janssen Research and Development, LLC , one of the Janssen Pharmaceutical Companies of Johnson & Johnson. 
• Mr. Brian Loew is the CEO of Inspire.
• Ms. Kimberly Richardson is a seven year survivor of ovarian cancer who was recently diagnosed with triple-positive breast cancer. 
• Dr. Carmen Guerra is an Associate Professor of Medicine, Vice Chair of Diversity and Inclusion in the Department of Medicine and Associate Director of Diversity and Outreach at the Abramson Cancer Center (ACC) at the Perelman School of Medicine, Penn . 
• Dr. Del Smith is the co-founder and CEO of Acclinate.  

For full transcript, please visit:https://sophiaconsultingfirm.com/blogs-%2B-articles/f/amplifying-scientific-innovation-clinical-trial-diversity-jpm-pt1?blogcategory=influential+leadership

In Episode 10, Season 4 of the Amplifying Scientific Innovation® Video Podcast, Dr. Sophia Ononye-Onyia, Founder and CEO of The Sophia Consulting Firm and Daré Board Director, interviewed Ms. Sabrina Johnson, President and CEO of Daré Bioscience, a leader in women's health innovation. In advance of International Women's Day 2022, Ms. Johnson shares her unique perspectives on science advocacy, health equity and influential leadership with a focus on women's health.  For full transcript, please visit https://sophiaconsultingfirm.com/blogs-%2B-articles/f/amplifying-scientific-innovation%C2%AE-sabrina-johnson-ceo-dar%C3%A9

In Episode 5, Season 4 of the Amplifying Scientific Innovation® Video Podcast, Dr. Sophia Ononye-Onyia, Founder and CEO of The Sophia Consulting Firm, interviewed Ms. Carmen Villar, Vice President of Social Business Innovation at Merck & Co where she oversees the Merck Foundation, the Merck Office of Corporate Responsibility, Merck for Mothers, and Merck Global Population Health. Known as MSD outside of the US and Canada, Merck’s mission is to save and improve lives around the world. In this recognition of Cervical Health Awareness Month, Ms. Villar discusses her perspectives on science advocacy, health equity and influential leadership.  For full transcript, please visit: https://sophiaconsultingfirm.com/blogs-%2B-articles/f/amplifying-scientific-innovation%C2%AE-carmen-villar-vp-merck

In the Season 4 Amplifying Scientific Innovation®:  JPM 2022 Health Equity Special, Dr. Sophia Ononye-Onyia, Founder and CEO of The Sophia Consulting Firm, interviewed Dr. Elizabeth Garner, Chief Medical Officer of ObsEva and the first Nigerian American to be featured on the podcast. ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. Here, Dr. Garner discusses her global perspectives on science advocacy, health equity and influential leadership.  For full transcript, please visit, https://sophiaconsultingfirm.com/blogs-%2B-articles/f/jpm-2022-health-equity-special-dr-elizabeth-garner-cmo-obseva

In the Season 4 premiere of the Amplifying Scientific Innovation Video Podcast, Dr. Sophia Ononye-Onyia, Founder and CEO of The Sophia Consulting Firm, interviewed Dr. John Whyte, Chief Medical Officer of WebMD, a leading provider of health information services. Here, Dr. Whyte discusses his perspectives on science advocacy, health equity and influential leadership. 

Special episode of the Amplifying Scientific Innovation video podcast that showcases analytics, featured companies and definitions of scientific innovation by the 15 guests featured on Season 2.